Drug Profile
Betahistine - Labopharm
Alternative Names: Once-Daily BetahistineLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Labopharm
- Class Amines; Anti-inflammatories; Antidementias; Pyridines; Small molecules; Vestibular disorder therapies
- Mechanism of Action Histamine H1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Vertigo
Most Recent Events
- 28 Oct 2004 Phase-I clinical trials in Vertigo in Canada (PO)
- 22 Sep 2003 Preclinical trials in Vertigo in Canada (PO)